H. Katagiri

发表

Lithium chloride inhibits thrombin-induced intracellular calcium mobilization in C6 rat glioma cells

S. Yamawaki, Y. Uchitomi, J. Horiguchi, 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effectiveness of valproate on delirium and/or aggressive behavior in demented patients: A practical pilot study.

H. Yamashita, S. Yamawaki, I. Miyoshi, 1998, International journal of psychiatry in clinical practice.

A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation

H. Katagiri, J. Gómez, K. Fujita, 2013, BMC Psychiatry.

Phase 2 randomized placebo‐controlled study of lasmiditan for the acute treatment of migraine in Japanese patients

T. Takeshima, H. Katagiri, Gosuke Homma, 2021, Headache.

Modulation of serotonin2a receptor function in rats after repeated treatment with dexamethasone and L-type calcium channel antagonist nimodipine

S. Yamawaki, S. Morinobu, A. Kagaya, 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Safety and effectiveness of rapid-acting intra-muscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study

H. Katagiri, Masanori Taketsuna, Kenta Kajimoto, 2018, Neuropsychiatric disease and treatment.

Safety and effectiveness of rapid-acting intra-muscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study

H. Katagiri, Masanori Taketsuna, Kenta Kajimoto, 2018, Neuropsychiatric disease and treatment.

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia

H. Katagiri, Masanori Taketsuna, Kenta Kajimoto, 2018, Neuropsychiatric disease and treatment.

Efficacy of olanzapine monotherapy in acute bipolar depression: a pooled analysis of controlled studies.

M. Tohen, S. Kanba, H. Katagiri, 2013, Journal of affective disorders.

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study

M. Tohen, S. Kanba, M. Case, 2013, BMC Psychiatry.

Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression.

M. Tohen, S. Kanba, Y. Fang, 2012, The British journal of psychiatry : the journal of mental science.

Efficacy of olanzapine in the treatment of bipolar mania with mixed features defined by DSM-5.

S. Kanba, R. McIntyre, H. Katagiri, 2014, Journal of affective disorders.

Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.

M. Tohen, S. Kanba, T. Higuchi, 2012, Journal of affective disorders.

Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder

M. Tohen, S. Kanba, T. Higuchi, 2012, Current medical research and opinion.

Efficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed features.

S. Kanba, R. McIntyre, H. Katagiri, 2014, Journal of affective disorders.

A polysomnographic study on periodic limb movements in patients with restless legs syndrome and neuroleptic-induced akathisia.

S. Yamawaki, H. Katagiri, J. Horiguchi, 1997, Hiroshima journal of medical sciences.

Safety and efficacy of olanzapine in the long‐term treatment of Japanese patients with bipolar I disorder, depression: An integrated analysis

M. Tohen, S. Kanba, M. Case, 2014, Psychiatry and clinical neurosciences.

Efficacy and Safety of Duloxetine in Children and Adolescents with Major Depressive Disorder in Japan: A Randomized Double-Blind Placebo-Controlled Clinical Trial Followed by an Open-Label Long-Term Extension Trial.

H. Matsumoto, Takuya Saito, H. Katagiri, 2022, Journal of child and adolescent psychopharmacology.

safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study

H. Katagiri, Masanori Taketsuna, Kenta Kajimoto, 2018 .

safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study

H. Katagiri, Masanori Taketsuna, Kenta Kajimoto, 2018 .